Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle
About this trial
The investigator proposes to use the cardiac coherence technique to diminish anxiety before the surgery of a peritoneal carcinosis of colon or stomach or ovary and pseudomyxoma or peritoneal mesothelioma.
Eligibility criteria
Qualifiers
Age over 18 years
Patients with peritoneal carcinosis awaiting cytoreductive surgery
Patients who scored strictly above 3 on the visual analogue anxiety scale and/or the psychological distress scale
Patients with sufficient command of the French language
Disqualifiers
Patients who already have daily practice of cardiac coherence
Presence of proven psychiatric disorders (e.g., mental retardation, psychotic disorders, learning disabilities, attention deficit/hyperactivity, bipolar disorder, etc.) other than mood disorders that are reactive to the disease experience, or receiving psychotic treatment that may impair thinking, judgment or discernment
Physical or sensory inability to respond to questionnaires
Patients who have had a heart transplant or bypass surgery in the Year before surgery
Trial design
Treatments tested in this trial
- Cardiac coherence
- Standard care
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov